FCRL5 and neoplasm: Infusion with FcRH5 CAR-T cells from two different donors could efficiently diminish the growth of luciferase-expressing NCI-H929 xenografts, as determined by IVIS imaging, and consequently prolonged the survival of the tumor-bearing mice.